<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4871865</article-id><article-id pub-id-type="doi">10.3389/fimmu.2016.00196</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>The Zebrafish Breathes New Life into the Study of Tuberculosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Myllym&#x000e4;ki</surname><given-names>Henna</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/306830"/></contrib><contrib contrib-type="author"><name><surname>B&#x000e4;uerlein</surname><given-names>Carina A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>R&#x000e4;met</surname><given-names>Mika</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>BioMediTech, University of Tampere</institution>, <addr-line>Tampere</addr-line>, <country>Finland</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Pediatrics, Tampere University Hospital</institution>, <addr-line>Tampere</addr-line>, <country>Finland</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Children and Adolescents, Oulu University Hospital</institution>, <addr-line>Oulu</addr-line>, <country>Finland</country></aff><aff id="aff4"><sup>4</sup><institution>PEDEGO Research Unit, Medical Research Center Oulu, University of Oulu</institution>, <addr-line>Oulu</addr-line>, <country>Finland</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Jason Paul Gigley, University of Wyoming, USA</p></fn><fn fn-type="edited-by"><p>Reviewed by: Marc S. Dionne, Imperial College London, UK; Philip Elks, University of Sheffield, UK</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Henna Myllym&#x000e4;ki, <email>henna.myllymaki@staff.uta.fi</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>19</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>7</volume><elocation-id>196</elocation-id><history><date date-type="received"><day>29</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>06</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 Myllym&#x000e4;ki, B&#x000e4;uerlein and R&#x000e4;met.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Myllym&#x000e4;ki, B&#x000e4;uerlein and R&#x000e4;met</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Tuberculosis (TB) is a global health emergency. Up to one-third of the world&#x02019;s population is infected with <italic>Mycobacterium tuberculosis</italic>, and the pathogen continues to kill 1.5 million people annually. Currently, the means for preventing, diagnosing, and treating TB are unsatisfactory. One of the main reasons for the poor progress in TB research has been a lack of good animal models to study the latency, dormancy, and reactivation of the disease. Although sophisticated <italic>in vitro</italic> and <italic>in silico</italic> methods suitable for TB research are constantly being developed, they cannot reproduce the complete vertebrate immune system and its interplay with pathogens and vaccines. However, the zebrafish has recently emerged as a useful alternative to more traditional models, such as mice, rabbits, guinea pigs, and non-human primates, for studying the complex pathophysiology of a mycobacterial infection. The model is based on the similarity between <italic>Mycobacterium marinum</italic> &#x02013; a natural fish pathogen &#x02013; and <italic>M. tuberculosis</italic>. In both zebrafish larvae and adult fish, an infection with <italic>M. marinum</italic> leads to the formation of macrophage aggregates and granulomas, which resemble the <italic>M. tuberculosis</italic> infections in humans. In this review, we will summarize the current status of the zebrafish model in TB research and highlight the advantages of using zebrafish to dissect mycobacterial virulence strategies as well as the host immune responses elicited against them. In addition, we will discuss the possibilities of using the adult zebrafish model for studying latency, dormancy, and reactivation in a mycobacterial infection.</p></abstract><kwd-group><kwd>tuberculosis</kwd><kwd>zebrafish model system</kwd><kwd>vaccination</kwd><kwd><italic>Mycobacterium marinum</italic></kwd><kwd><italic>Mycobacterium tuberculosis</italic></kwd><kwd><italic>Mycobacterium</italic> infections</kwd><kwd>granuloma</kwd><kwd>latency</kwd></kwd-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="92"/><page-count count="9"/><word-count count="6680"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Tuberculosis (TB) is still the world&#x02019;s second deadliest infectious disease killing 1.5 million people and with an estimated 9.6 million new cases reported to the WHO in 2015 (<xref rid="B1" ref-type="bibr">1</xref>). An estimated one-third of the world&#x02019;s population has been exposed to TB. 5&#x02013;10% of these latent carriers will eventually develop the active disease (<xref rid="B1" ref-type="bibr">1</xref>).</p><p>The causative agent of TB, <italic>Mycobacterium tuberculosis</italic>, spreads through the air (Figure <xref ref-type="fig" rid="F1">1</xref>A). Alveolar macrophages phagocytose the inhaled mycobacteria and transport them into the lung tissues (<xref rid="B2" ref-type="bibr">2</xref>). A cascade of pro- and anti-inflammatory signaling leads to the recruitment and accumulation of additional macrophages and other leukocytes in the pulmonary tissues. Eventually, the formation of granulomas, the hallmark of pathological TB, is initiated. The granuloma is a heterogeneous, but well-organized, and dynamic accumulation of immune cells, including blood-derived infected and uninfected macrophages, foamy macrophages, and epithelioid cells (<xref rid="B3" ref-type="bibr">3</xref>). The inner cell mass is usually surrounded by a ring of leukocytes and fibroblasts (<xref rid="B4" ref-type="bibr">4</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>A; Table <xref ref-type="table" rid="T1">1</xref>). The localization and control of the bacteria and the restriction of the immune response to a defined area are generally regarded as the main functions of granulomas (<xref rid="B5" ref-type="bibr">5</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Granuloma formation in human <italic>Mycobacterium tuberculosis</italic> infection and in zebrafish <italic>M. marinum</italic> infection</bold>. <bold>(A)</bold><italic>M. tuberculosis</italic> spreads as an aerosol, and first infects alveolar macrophages. In most individuals, the infection is maintained in a latent, subclinical state, which is characterized by the formation of granulomas (left). The mature granulomas have a caseous, necrotic core, surrounded by infected macrophages and lymphocytes. Upon reactivation, the granulomas are disrupted, causing cavities in the lungs. The mycobacteria escape from the granulomas and are disseminated in cough droplets, which facilitates the transmission of the disease. <bold>(B)</bold> Upon infection with <italic>M. marinum</italic>, the granulomas in the zebrafish embryo develop within a few days and mainly consist of infected and uninfected macrophages and recruited neutrophils. <bold>(C)</bold> Depending on the bacterial dose, the adult zebrafish <italic>M. marinum</italic> infection can lead to a latent or an active, progressive disease. A latent infection is characterized by the formation of granulomas in various organs. As the early granulomas mature, their inner parts become caseous and surrounded by a fibrous wall. The zebrafish with a latent infection remain asymptomatic. A (re)activated, progressive mycobacterial infection is characterized by the disruption of the granulomatous structures, rapid replication and dissemination of mycobacteria and profound tissue damage. Eventually, a progressive mycobacterial disease will lead to death in most fish. The zebrafish granulomas were visualized with Ziehl&#x02013;Neelsen staining, mycobacteria are seen as purple rods. cfu, colony-forming unit.</p></caption><graphic xlink:href="fimmu-07-00196-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p><bold>Characteristics of a mycobacterial infection in humans, adult zebrafish, and zebrafish embryos</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th valign="top" align="left" rowspan="1" colspan="1">Human</th><th valign="top" align="left" rowspan="1" colspan="1">Adult zebrafish (&#x0003e;3&#x02009;months)</th><th valign="top" align="left" rowspan="1" colspan="1">Zebrafish embryo (&#x0003c;6&#x02009;days)</th><th valign="top" align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Immune system</bold></td><td align="left" valign="top" rowspan="1" colspan="1">Innate and adaptive</td><td align="left" valign="top" rowspan="1" colspan="1">Innate and adaptive</td><td align="left" valign="top" rowspan="1" colspan="1">Innate only</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mycobacterial pathogen</td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Mycobacterium tuberculosis</italic> and atypical mycobacteria including <italic>Mycobacterium marinum</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Mycobacterium marinum</italic></td><td align="left" valign="top" rowspan="1" colspan="1"><italic>Mycobacterium marinum</italic></td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Natural susceptibility</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">Yes</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B12" ref-type="bibr">12</xref>)</td></tr><tr><td align="left" valign="top" rowspan="4" colspan="1">Infection route and infectious dose</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Natural infection</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Airways ID<sub>50</sub> &#x0003c;10 bacilli</td><td align="left" valign="top" rowspan="1" colspan="1">Digestive tract</td><td align="left" valign="top" rowspan="1" colspan="1">?</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B12" ref-type="bibr">12</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<bold>Experimental infection</bold></td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N/A</td><td align="left" valign="top" rowspan="1" colspan="1">Multiple injection techniques, intraperitoneal injection is the most commonly used; &#x0003c;30&#x02013;10,000&#x02009;cfu</td><td align="left" valign="top" rowspan="1" colspan="1">Multiple injection techniques, caudal injection is the most commonly used; &#x0003c;10&#x02013;&#x0003e;300&#x02009;cfu</td><td align="left" valign="top" rowspan="1" colspan="1">(<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>)</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Infection phases</td><td align="left" valign="top" rowspan="1" colspan="1">Acute</td><td align="left" valign="top" rowspan="1" colspan="1">Acute</td><td align="left" valign="top" rowspan="3" colspan="1">Progressive?</td><td align="left" valign="top" rowspan="3" colspan="1">(<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B17" ref-type="bibr">17</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Latent</td><td align="left" valign="top" rowspan="1" colspan="1">Latent</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reactivation</td><td align="left" valign="top" rowspan="1" colspan="1">Reactivation</td></tr><tr><td align="left" valign="top" rowspan="3" colspan="1">Granuloma types</td><td align="left" valign="top" rowspan="1" colspan="1">Early</td><td align="left" valign="top" rowspan="1" colspan="1">Early</td><td align="left" valign="top" rowspan="3" colspan="1">Primitive?</td><td align="left" valign="top" rowspan="3" colspan="1">(<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fibrous</td><td align="left" valign="top" rowspan="1" colspan="1">Fibrous</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Necrotic</td><td align="left" valign="top" rowspan="1" colspan="1">Necrotic</td></tr><tr><td align="left" valign="top" rowspan="6" colspan="1">Cell types involved in granuloma formation</td><td align="left" valign="top" rowspan="1" colspan="1">Macrophages</td><td align="left" valign="top" rowspan="1" colspan="1">Macrophages</td><td align="left" valign="top" rowspan="1" colspan="1">Macrophages</td><td align="left" valign="top" rowspan="6" colspan="1">(<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils</td><td align="left" valign="top" rowspan="1" colspan="1">Neutrophils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dendritic cells</td><td align="left" valign="top" rowspan="1" colspan="1">Dendritic cells</td><td align="left" valign="top" rowspan="1" colspan="1">Epithelial cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lymphocytes (T cells, B cells, and NK cells)</td><td align="left" valign="top" rowspan="1" colspan="1">Lymphocytes (T cells and B cells)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fibroblasts</td><td align="left" valign="top" rowspan="1" colspan="1">Epithelial cells</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Epithelial cells</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>Mycobacteria can persist asymptomatic within the granuloma for decades. However, a dysregulation of the immune system can reactivate the mycobacteria, which leads to disease progression (secondary TB) (<xref rid="B2" ref-type="bibr">2</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>A) Primary TB mainly occurs in children, who are at the highest risk for TB meningitis and a disseminated form of the disease (<xref rid="B19" ref-type="bibr">19</xref>).</p><p>Efforts to eradicate TB are obstructed by the lack of unambiguous diagnostic tools, the lengthy antibiotic treatments required for curation, the growing problem of multi-drug-resistant bacteria, and the poor protection provided by the Bacillus Calmette&#x02013;Gu&#x000e9;rin (BCG), the only vaccine available (<xref rid="B1" ref-type="bibr">1</xref>). As a live vaccine, BCG imposes a risk of a disseminated infection in immunocompromised patients (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>). Thus, there is a need to develop new effective drugs and vaccines against TB. For this purpose, relevant animal models are essential. The most commonly used animal models in TB research are mice, guinea pigs, and non-human primates (NHP), all of which have their limitations related to either space, costs, ethical aspects, or their ability to replicate the human disease pathology (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Recently, the zebrafish&#x02013;<italic>M. marinum</italic> model has gained popularity as a natural pathogen&#x02013;host system that closely recapitulates the pathology of human TB (Table <xref ref-type="table" rid="T1">1</xref>) (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B23" ref-type="bibr">23</xref>). The infection model and its applications are discussed in more detail below.</p></sec><sec id="S2"><title>The Zebrafish&#x02013;<italic>Mycobacterium marinum</italic> Infection Model</title><p><italic>Mycobacterium marinum</italic>, the causative agent of fish mycobacteriosis, is a close relative of <italic>M. tuberculosis</italic> (<xref rid="B24" ref-type="bibr">24</xref>). <italic>M. marinum</italic> spreads <italic>via</italic> water, and it also occasionally infects humans, but the infection is usually limited to the skin (fish tank granuloma) (<xref rid="B11" ref-type="bibr">11</xref>). Thus, <italic>M. marinum</italic> is safer to work with and has a shorter replication time than <italic>M. tuberculosis</italic> (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B23" ref-type="bibr">23</xref>). Similar to human TB, fish mycobacteriosis displays an acute and chronic form and the subsequently formed granulomas also resemble the lesions caused by <italic>M. tuberculosis</italic> [Figure <xref ref-type="fig" rid="F1">1</xref> (<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>)]. Both bacteria are able to survive and replicate within macrophages (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B25" ref-type="bibr">25</xref>). In a laboratory setting, the zebrafish is an advantageous choice as a host organism for <italic>M. marinum</italic> for several reasons: multiple infection techniques can be used for both zebrafish embryos and adults (<xref rid="B26" ref-type="bibr">26</xref>); for a review, see Ref. (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B27" ref-type="bibr">27</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>) (Figures <xref ref-type="fig" rid="F1">1</xref>B,C). The transparency of the embryos allows the use of sophisticated <italic>in vivo</italic> real-time imaging techniques, including multiple leukocyte and macrophage fluorescent reporter lines (<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B32" ref-type="bibr">32</xref>), and several techniques for genetic manipulation (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B35" ref-type="bibr">35</xref>). Moreover, zebrafish are small in size, and produce numerous offspring, making them also suitable for large-scale screening studies, including drug screens (<xref rid="B6" ref-type="bibr">6</xref>). Despite the anatomical differences between fish and mammals, the zebrafish is a vertebrate model with an innate and adaptive immunity consisting of the same primary components as present in humans (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>). As zebrafish lack lymph nodes, immune cells mainly develop and perform their functions in the spleen, the kidney, and the thymus (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>). Zebrafish embryos rely solely on innate immunity. In the embryos, functional macrophages and neutrophils emerge 1 and 2&#x02009;days post-fertilization (dpf), respectively, while lymphocytes start developing after 4&#x02009;dpf and the adaptive immunity becomes fully functional at 4&#x02009;weeks post-fertilization (wpf) (<xref rid="B7" ref-type="bibr">7</xref>). This facilitates studying the function of the innate and adaptive immune system, as well as different cell types, separately (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B33" ref-type="bibr">33</xref>).</p></sec><sec id="S3"><title>Host&#x02013;<italic>Mycobacterium</italic> Interactions &#x02013; Insights into Early Infection Events from Zebrafish Larvae</title><p>Zebrafish larvae have been especially useful in elucidating the role of macrophages and the strategies the phagocytosed mycobacteria use to suppress phagosomal maturation, apoptosis, and the antibacterial innate immune response (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B40" ref-type="bibr">40</xref>). Scavenger receptors of different classes have been studied in the context of the phagocytosis of mycobacteria. For example, Marco binds the glycolipid trehalose 6,69-dimycolate on the mycobacterial cell wall and affects the regulation of the subsequent proinflammatory response (<xref rid="B41" ref-type="bibr">41</xref>). CD36 also appears to be involved in mycobacterial control, though its role and the regulation of its expression seem quite complicated (<xref rid="B42" ref-type="bibr">42</xref>). Following phagocytosis, Toll-like receptor (TLR) signaling <italic>via</italic> MyD88 is needed for resistance against an early mycobacterial infection (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>). For example, the activation of the TLR signaling leads to the production of antibacterial molecules by macrophages, such as the perforin Mpeg1.2 (<xref rid="B45" ref-type="bibr">45</xref>). In the zebrafish, the <italic>myd88</italic><sup>&#x02212;/&#x02212;</sup> mutants have been a useful tool in elucidating the role of TLR signaling in mycobacterial resistance (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>).</p><p>Toll-like receptor signaling is involved in the initiation of the production of reactive oxygen and nitrogen species (ROS and RNS, respectively). In the zebrafish, early stabilization of the transcription factor hypoxia-inducible factor 1&#x003b1; (Hif-1&#x003b1;) in neutrophils limits bacterial growth by inducing iNOS, which in turn leads to increased protein nitrosylation (<xref rid="B48" ref-type="bibr">48</xref>). Later in the course of the infection, this response is decreased in the developing granulomas by a mechanism independent of the early secretory antigenic target 6 system 1/region of difference 1 (ESX-1/RD1) virulence locus (<xref rid="B49" ref-type="bibr">49</xref>).</p><p>As a mean to counteract the mycobacterial evasion strategies, the host can induce autophagy, a process which enables cells to digest their cytoplasmic contents, including microorganisms and membranous structures, in lysosomes (<xref rid="B50" ref-type="bibr">50</xref>). This is dependent on TLR signaling and Myd88, which are linked <italic>via</italic> the DNA damage-regulated autophagy modulator DRAM1. DRAM1 is needed for the formation of autophagosomes and for their fusion with lysosomes, while a DRAM1 deficiency leads to defects in maintaining the mycobacteria inside vesicles in macrophages and in the control of mycobacterial growth (<xref rid="B51" ref-type="bibr">51</xref>), Again, zebrafish larvae provide feasible tools for observing the events of autophagy <italic>in vivo</italic> and in real-time utilizing both light and electron microscopy, including the GFP-Lc3-transgenic line, for the visualization of autophagosomal structures (<xref rid="B52" ref-type="bibr">52</xref>).</p></sec><sec id="S4"><title>Zebrafish Larvae Model Challenge Old Dogmas in Mycobacterial Resistance</title><p>After a successful infection by mycobacteria, granulomas are seeded. The granulomas in zebrafish embryos mainly consist of aggregated macrophages, intra- and extracellular mycobacteria, together with recruited neutrophils, and form within a few days post-infection (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B53" ref-type="bibr">53</xref>); for a review, see Ref. (<xref rid="B54" ref-type="bibr">54</xref>). Despite their rather primitive structure, the embryonic zebrafish granulomas provide a physiological model for studying cellular processes affecting mycobacterial infections, such as the generation of hypoxia and angiogenesis. Injection of mycobacteria into the caudal vein results in the development of non-hypoxic granulomas in the richly vascularized area of the caudal hematopoietic tissue (<xref rid="B48" ref-type="bibr">48</xref>). In contrast, granulomas resulting from a trunk infection reside in a sparsely vascularized area and can become hypoxic and induce vascularization (<xref rid="B55" ref-type="bibr">55</xref>).</p><p>Importantly, studies on early granulomas in zebrafish larvae have challenged some of the old dogmas. In general, granulomas have long been considered a protection mechanism elicited by the host. However, recent evidence from zebrafish embryos suggests that <italic>M. marinum</italic> uses the macrophages and granulomas for its own expansion and dissemination (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). The bacteria can recruit new, uninfected macrophages to the granuloma site using the RD1 locus (<xref rid="B16" ref-type="bibr">16</xref>). The arriving macrophages phagocytize infected, dead cells and thus contribute to the spreading of the bacteria. The recruitment of new macrophages is enhanced by the bacteria by ESAT-6-mediated production of matrix metalloproteinase 9 (<xref rid="B17" ref-type="bibr">17</xref>). Mycobacteria also need the RD1 locus for escaping from the phagosomes into the cytoplasm of infected macrophages both in human cells and in zebrafish (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B56" ref-type="bibr">56</xref>). Additionally, mycobacteria use cell surface lipids to mask pathogen-associated molecular patterns, hence selectively infect permissive macrophages and avoid microbicidal ones (<xref rid="B57" ref-type="bibr">57</xref>). Thus, granulomas present a combat zone for the host immune system and the bacterial response, rather than purely a protection mechanism of the host to prevent the spread of bacteria (<xref rid="B4" ref-type="bibr">4</xref>).</p><p>In addition to basic research, the zebrafish larvae provide a feasible tool for early-stage drug development and large-scale screens (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>). Two major, and related, issues in improving the TB drug development are the lengthiness of the curative treatments and the increasing emergence of drug-resistant bacteria (<xref rid="B1" ref-type="bibr">1</xref>). Discoveries made in zebrafish larvae revealed that intracellular mycobacteria use their efflux pumps to acquire a tolerance against the antibiotics commonly used to treat human TB, which allows the bacteria to persist and replicate in the cytosol. <italic>M. tuberculosis</italic> uses the same mechanism (<xref rid="B60" ref-type="bibr">60</xref>). However, this tolerance was reversed by an efflux pump inhibitor, such as verapamil, which can therefore reduce the tolerance to antibiotics and thereby shorten treatment times (<xref rid="B61" ref-type="bibr">61</xref>). These results prove that the zebrafish larval model can replicate the function of antitubercular compounds (<xref rid="B60" ref-type="bibr">60</xref>). In addition, angiogenesis has been shown to be important for granuloma formation. Therefore, targeting vascularization, for example, by inhibiting vascular endothelial growth factor receptor (VEGFR) signaling could provide a means to target mycobacterial infections and inhibit mycobacterial dissemination, resembling the strategy used in cancer therapies (<xref rid="B55" ref-type="bibr">55</xref>).</p><p>On the host&#x02019;s side, cytokines and their respective receptors play an important role in protection against mycobacteria. For example, the signaling axis mediated by chemokine CXC-motive containing receptor 3 (CXCR3) has been implicated in mycobacterial spreading and could thus provide a therapeutic target (<xref rid="B62" ref-type="bibr">62</xref>). In addition, in both humans and zebrafish larvae the leukotriene A4 hydrolase (LTA4H) locus controls pro- and anti-inflammatory mediators that in turn control the expression of TNF (<xref rid="B63" ref-type="bibr">63</xref>). While TNF is required for the host response against mycobacteria, its excess renders the host more susceptible to an infection, highlighting the importance of a balanced response (<xref rid="B64" ref-type="bibr">64</xref>). Thus, the zebrafish can elucidate the pathways controlling the host immune responses, and this information can be further applied to targeting these pathways with new drugs and developing host-directed therapies (<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B63" ref-type="bibr">63</xref>&#x02013;<xref rid="B66" ref-type="bibr">66</xref>). In addition, further investigation into the evasion strategies that mycobacteria use to interfere with the host defense mechanisms can potentially lead to the discovery of novel drug targets to combat mycobacterial diseases (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B67" ref-type="bibr">67</xref>).</p></sec><sec id="S5"><title>Mycobacterial Latency vs. Adaptive Immunity &#x02013; The Adult Zebrafish as a Model for TB</title><p>One of the main advantages of the zebrafish&#x02013;<italic>M. marinum</italic> model may lie in granuloma formation, which has not been easy to reproduce in the traditional model animals (<xref rid="B22" ref-type="bibr">22</xref>). In the adult zebrafish, however, the histology of the mature granulomas resembles those seen in human TB with their caseous, necrotic core surrounded by leukocytes and epithelial cells (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B17" ref-type="bibr">17</xref>). Granulomas are found in various organs such as the pancreas, gonads, spleen, and liver several weeks post-infection (Figure <xref ref-type="fig" rid="F1">1</xref>C) (<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>).</p><p>The latency of TB is another aspect that has been difficult to replicate experimentally (<xref rid="B22" ref-type="bibr">22</xref>). As this is also challenging to study in humans, our knowledge of the required immunological mechanisms for the control of a mycobacterial infection at its different stages remains limited (<xref rid="B17" ref-type="bibr">17</xref>). However, this could be improved by studying the zebrafish model, as like humans, adult zebrafish develop a latent, non-progressive disease with dormant bacteria residing within well-structured granulomas, and the fish remain asymptomatic (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). Moreover, reactivation of the bacteria can occur spontaneously, or can be induced experimentally by an immune deficiency, such as exposure to &#x003b3;-irradiation. In either case, reactivation will lead to the active spreading of the bacteria and the development of symptoms similar to an active infection as well as high lethality, much as in human TB (<xref rid="B13" ref-type="bibr">13</xref>).</p><p>Although the early cytokine response mediated by the innate immunity plays an important role in determining whether a mycobacterial infection leads to an acute or latent disease, the adaptive immunity is also required to control the bacteria. This is seen in the adult <italic>rag</italic><sup>&#x02212;/&#x02212;</sup> zebrafish that are devoid of lymphocytes. The mutant fish are unable to generate a latent state of the infection and are, therefore, hypersusceptible to <italic>M. marinum</italic> (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B68" ref-type="bibr">68</xref>). So far, the significance of different lymphocyte subsets has not been extensively studied in the zebrafish mycobacterial infection. Nevertheless, Th1 as well as Th2 cells seem to be involved in the effective control of mycobacterial infections (<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B70" ref-type="bibr">70</xref>). Interestingly, a novel Th2-like subset of cells capable of inhibiting the growth of <italic>M. tuberculosis</italic> has been found in human TB patients. This observation challenges the old idea that only Th1 cells are important for mycobacterial control (<xref rid="B71" ref-type="bibr">71</xref>). Genetic differences in the mycobacterial strains also seem to affect their virulence, for example, strains isolated from infected humans more commonly causing an acute disease, and isolates from poikilothermic species causing a chronic infection in the zebrafish (<xref rid="B72" ref-type="bibr">72</xref>).</p><p>While the zebrafish larvae provide a feasible tool for screening for drugs against TB, the adult zebrafish appears to be a promising model for early vaccine development. The zebrafish can be partially protected against mycobacteriosis by BCG (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B73" ref-type="bibr">73</xref>) or attenuated <italic>M. marinum</italic> (<xref rid="B74" ref-type="bibr">74</xref>), suggesting the use of adult zebrafish as a model for studying the feasibility of conserved mycobacterial antigens as vaccines. For example, the RD1 virulence locus and the ESX-1 secretion system, which are absent from BCG, have been shown to be important for virulence in <italic>M. tuberculosis</italic>. In <italic>M. marinum</italic>, RD1 is also is also required for granuloma formation in both larvae and adult fish (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B76" ref-type="bibr">76</xref>). Indeed, the antigens in this region do show some potential as targets for vaccines in the zebrafish as well as in other models (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B77" ref-type="bibr">77</xref>&#x02013;<xref rid="B79" ref-type="bibr">79</xref>). The zebrafish can also provide a feasible model for searching for the most effective antigen combinations and for studying different vaccination strategies. For instance, a DNA-based vaccine consisting of three mycobacterial antigens (Ag85, ESAT-6, and CFP10), which has also been studied in other TB models, confers protection against mycobacteria in zebrafish (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B80" ref-type="bibr">80</xref>&#x02013;<xref rid="B82" ref-type="bibr">82</xref>). Furthermore, the effect of BCG can be boosted by a DNA vaccine (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B80" ref-type="bibr">80</xref>&#x02013;<xref rid="B82" ref-type="bibr">82</xref>). Adult zebrafish could therefore be used for developing vaccines for both replacing and boosting BCG, as well as for studying the immunological correlates required for protection.</p></sec><sec sec-type="discussion" id="S6"><title>Discussion</title><p>The lack of an animal model that recapitulates the human disease stages and pathology has in part hampered the development of new drugs, vaccines, and diagnostic tools against TB (<xref rid="B22" ref-type="bibr">22</xref>). Even though the mammalian animal models mostly used for TB research, namely, mice, rabbits, and guinea pigs, do develop granulomatous structures, only primates are a natural host for <italic>M. tuberculosis</italic> and show true latency and reactivation (<xref rid="B83" ref-type="bibr">83</xref>). However, the use of primates as laboratory animals is difficult in terms of ethical and economic issues as well as space limitations. When drug and vaccine development is considered, a natural host&#x02013;pathogen pair is likely to be a more reliable model. Moreover, choosing to work with (zebra)fish might have an additional practical advantage: as mycobacterial infections are able to cause epidemics in fish farms, aquariums, and zebrafish facilities (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B84" ref-type="bibr">84</xref>), vaccinating fish against <italic>M. marinum</italic> is of potential economic and ecological relevance. This has been studied to some extent, for example, in the striped bass with the Ag85A DNA vaccine (<xref rid="B85" ref-type="bibr">85</xref>) and in the Japanese flounder with BCG (<xref rid="B86" ref-type="bibr">86</xref>). Thus, the results obtained in human biomedical research and veterinary studies could potentially augment each other.</p><p>The zebrafish&#x02013;<italic>M. marinum</italic> infection exhibits essentially the same disease phases as those seen in human TB, including latency and reactivation &#x02013; either spontaneously or following immunosuppression (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>). This might have important implications as the different disease phases probably also represent on the one hand different strategies of bacterial adaptation, and on the other hand, different stages of the host immune response (<xref rid="B87" ref-type="bibr">87</xref>). Since these aspects can be replicated in the zebrafish infection, the model should facilitate a more detailed dissection of both the effective (and deleterious) immune responses and the bacterial counter strategies in each stage of the infection. The zebrafish model can also be used to complement the human patient data in the identification of reliable biomarkers for the diagnosis of the different stages of TB (<xref rid="B88" ref-type="bibr">88</xref>).</p><p>Besides biomarkers, new drugs and vaccines are needed to combat TB. For this, a better knowledge concerning the correlates of a protective immune response is essential (<xref rid="B89" ref-type="bibr">89</xref>). The HI virus attacks CD4<sup>+</sup> T cells, and a co-infection renders the patients highly susceptible to TB. Therefore, it seems that CD4<sup>+</sup> T cells are important for the host response (<xref rid="B90" ref-type="bibr">90</xref>). This does not mean, however, that the study of other cell types should be neglected, as they too can reveal new immunological mechanisms (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B71" ref-type="bibr">71</xref>). Moreover, deficiencies in the IFN-&#x003b3; signaling axis lead to hypersusceptibility toward TB, and thus IFN-&#x003b3; expression has been associated with protection against the disease (<xref rid="B90" ref-type="bibr">90</xref>). However, despite inducing high levels of IFN-&#x003b3; production, a promising vaccine candidate, MVA85A, failed recently to enhance protection in an efficacy trial (<xref rid="B91" ref-type="bibr">91</xref>). This suggests that it is unlikely that a single immunological factor could predict the course of a TB infection (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B92" ref-type="bibr">92</xref>). Thus, there are still gaps in our knowledge of how an effective host defense against TB is elicited, and relevant animal models are needed to fill in the missing information. Furthermore, once the picture of protection mechanisms is more complete, the animal models can aid us in translating this information into the benefit of clinical medicine. We believe the zebrafish will be an important player in fulfilling both of these tasks.</p></sec><sec id="S7"><title>Author Contributions</title><p>All authors contributed to planning and writing the manuscript and designing of the figures.</p></sec><sec id="S8"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We thank Dr. Helen Cooper for revising the language of the manuscript and MSc Mirja Niskanen for technical help with histology and MSc Meri Uusi-M&#x000e4;kel&#x000e4; for help with the figure.</p></ack><sec id="S9"><title>Funding</title><p>This work was supported by the Foundation of the Finnish Anti-Tuberculosis Association (HM), the Tampere Tuberculosis Foundation (HM and MR), the Finnish Academy (MR) (grant number on 277495), the Sigrid Juselius Foundation (MR), the Jane and Aatos Erkko Foundation (MR), the Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (MR), and Competitive State Research Financing of the Expert Responsibility area of Oulu University Hospital (MR).</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="webpage"><collab>World Health Organization</collab>. <source>Global Tuberculosis Report 2015</source>. (<year>2015</year>). Available from: <uri xlink:type="simple" xlink:href="http://www.who.int/tb/publications/global_report/en/">http://www.who.int/tb/publications/global_report/en/</uri></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frieden</surname><given-names>TR</given-names></name><name><surname>Sterling</surname><given-names>TR</given-names></name><name><surname>Munsiff</surname><given-names>SS</given-names></name><name><surname>Watt</surname><given-names>CJ</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name></person-group>. <article-title>Tuberculosis</article-title>. <source>Lancet</source> (<year>2003</year>) <volume>362</volume>:<fpage>887</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(03)14333-4</pub-id><?supplied-pmid 13678977?><pub-id pub-id-type="pmid">13678977</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>DO</given-names></name></person-group>
<article-title>The structure of mononuclear phagocytes differentiating in vivo. I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG)</article-title>. <source>Am J Pathol</source> (<year>1974</year>) <volume>76</volume>:<fpage>17</fpage>&#x02013;<lpage>48</lpage>.<pub-id pub-id-type="pmid">4601921</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Revisiting the role of the granuloma in tuberculosis</article-title>. <source>Nat Rev Immunol</source> (<year>2012</year>) <volume>12</volume>:<fpage>352</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1038/nri3211</pub-id><?supplied-pmid 22517424?><pub-id pub-id-type="pmid">22517424</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>DO</given-names></name></person-group>
<article-title>The granulomatous inflammatory response. A review</article-title>. <source>Am J Pathol</source> (<year>1976</year>) <volume>84</volume>(<issue>1</issue>):<fpage>164</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">937513</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Trede</surname><given-names>NS</given-names></name></person-group>. <article-title>A model 450 million years in the making: zebrafish and vertebrate immunity</article-title>. <source>Dis Model Mech</source> (<year>2012</year>) <volume>5</volume>:<fpage>38</fpage>&#x02013;<lpage>47</lpage>.<pub-id pub-id-type="doi">10.1242/dmm.007138</pub-id><?supplied-pmid 22228790?><pub-id pub-id-type="pmid">22228790</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langenau</surname><given-names>DM</given-names></name><name><surname>Ferrando</surname><given-names>AA</given-names></name><name><surname>Traver</surname><given-names>D</given-names></name><name><surname>Kutok</surname><given-names>JL</given-names></name><name><surname>Hezel</surname><given-names>JP</given-names></name><name><surname>Kanki</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title>In vivo tracking of T cell development, ablation, and engraftment in transgenic zebrafish</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2004</year>) <volume>101</volume>:<fpage>7369</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0402248101</pub-id><pub-id pub-id-type="pmid">15123839</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>AH</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name></person-group>. <article-title>Host-pathogen interactions made transparent with the zebrafish model</article-title>. <source>Curr Drug Targets</source> (<year>2011</year>) <volume>12</volume>:<fpage>1000</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.2174/138945011795677809</pub-id><?supplied-pmid 21366518?><pub-id pub-id-type="pmid">21366518</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decostere</surname><given-names>A</given-names></name><name><surname>Hermans</surname><given-names>K</given-names></name><name><surname>Haesebrouck</surname><given-names>F</given-names></name></person-group>. <article-title>Piscine mycobacteriosis: a literature review covering the agent and the disease it causes in fish and humans</article-title>. <source>Vet Microbiol</source> (<year>2004</year>) <volume>99</volume>:<fpage>159</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetmic.2003.07.011</pub-id><?supplied-pmid 15066718?><pub-id pub-id-type="pmid">15066718</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Garra</surname><given-names>A</given-names></name><name><surname>Redford</surname><given-names>PS</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Bloom</surname><given-names>CI</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name><name><surname>Berry</surname><given-names>MP</given-names></name></person-group>. <article-title>The immune response in tuberculosis</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<fpage>475</fpage>&#x02013;<lpage>527</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095939</pub-id><?supplied-pmid 23516984?><pub-id pub-id-type="pmid">23516984</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linell</surname><given-names>F</given-names></name><name><surname>Norden</surname><given-names>A</given-names></name></person-group>
<article-title><italic>Mycobacterium balnei</italic>, a new acid-fast bacillus occurring in swimming pools and capable of producing skin lesions in humans</article-title>. <source>Acta Tuberc Scand Suppl</source> (<year>1954</year>) <volume>33</volume>:<fpage>1</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">13188762</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harriff</surname><given-names>MJ</given-names></name><name><surname>Bermudez</surname><given-names>LE</given-names></name><name><surname>Kent</surname><given-names>ML</given-names></name></person-group>. <article-title>Experimental exposure of zebrafish, <italic>Danio rerio</italic> (Hamilton), to <italic>Mycobacterium marinum</italic> and <italic>Mycobacterium peregrinum</italic> reveals the gastrointestinal tract as the primary route of infection: a potential model for environmental mycobacterial infection</article-title>. <source>J Fish Dis</source> (<year>2007</year>) <volume>30</volume>:<fpage>587</fpage>&#x02013;<lpage>600</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2761.2007.00839.x</pub-id><?supplied-pmid 17850575?><pub-id pub-id-type="pmid">17850575</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parikka</surname><given-names>M</given-names></name><name><surname>Hammaren</surname><given-names>MM</given-names></name><name><surname>Harjula</surname><given-names>SK</given-names></name><name><surname>Halfpenny</surname><given-names>NJ</given-names></name><name><surname>Oksanen</surname><given-names>KE</given-names></name><name><surname>Lahtinen</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium marinum</italic> causes a latent infection that can be reactivated by gamma irradiation in adult zebrafish</article-title>. <source>PLoS Pathog</source> (<year>2012</year>) <volume>8</volume>:<fpage>e1002944</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1002944</pub-id><?supplied-pmid 23028333?><pub-id pub-id-type="pmid">23028333</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swaim</surname><given-names>LE</given-names></name><name><surname>Connolly</surname><given-names>LE</given-names></name><name><surname>Volkman</surname><given-names>HE</given-names></name><name><surname>Humbert</surname><given-names>O</given-names></name><name><surname>Born</surname><given-names>DE</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title><italic>Mycobacterium marinum</italic> infection of adult zebrafish causes caseating granulomatous tuberculosis and is moderated by adaptive immunity</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<fpage>6108</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00887-06</pub-id><?supplied-pmid 17057088?><pub-id pub-id-type="pmid">17057088</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prouty</surname><given-names>MG</given-names></name><name><surname>Correa</surname><given-names>NE</given-names></name><name><surname>Barker</surname><given-names>LP</given-names></name><name><surname>Jagadeeswaran</surname><given-names>P</given-names></name><name><surname>Klose</surname><given-names>KE</given-names></name></person-group>
<article-title>Zebrafish-<italic>Mycobacterium marinum</italic> model for mycobacterial pathogenesis</article-title>. <source>FEMS Microbiol Lett</source> (<year>2003</year>) <volume>225</volume>:<fpage>177</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/S0378-1097(03)00446-4</pub-id><pub-id pub-id-type="pmid">12951238</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>The role of the granuloma in expansion and dissemination of early tuberculous infection</article-title>. <source>Cell</source> (<year>2009</year>) <volume>136</volume>:<fpage>37</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2008.11.014</pub-id><?supplied-pmid 19135887?><pub-id pub-id-type="pmid">19135887</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkman</surname><given-names>HE</given-names></name><name><surname>Pozos</surname><given-names>TC</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Rawls</surname><given-names>JF</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium</article-title>. <source>Science</source> (<year>2010</year>) <volume>327</volume>:<fpage>466</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1126/science.1179663</pub-id><?supplied-pmid 20007864?><pub-id pub-id-type="pmid">20007864</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Clay</surname><given-names>H</given-names></name><name><surname>Lewis</surname><given-names>JL</given-names></name><name><surname>Ghori</surname><given-names>N</given-names></name><name><surname>Herbomel</surname><given-names>P</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos</article-title>. <source>Immunity</source> (<year>2002</year>) <volume>17</volume>:<fpage>693</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(02)00475-2</pub-id><?supplied-pmid 12479816?><pub-id pub-id-type="pmid">12479816</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marais</surname><given-names>BJ</given-names></name><name><surname>Gie</surname><given-names>RP</given-names></name><name><surname>Schaaf</surname><given-names>HS</given-names></name><name><surname>Beyers</surname><given-names>N</given-names></name><name><surname>Donald</surname><given-names>PR</given-names></name><name><surname>Starke</surname><given-names>JR</given-names></name></person-group>. <article-title>Childhood pulmonary tuberculosis: old wisdom and new challenges</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2006</year>) <volume>173</volume>:<fpage>1078</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200511-1809SO</pub-id><?supplied-pmid 16484674?><pub-id pub-id-type="pmid">16484674</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A</given-names></name><name><surname>Eisenhut</surname><given-names>M</given-names></name><name><surname>Harris</surname><given-names>RJ</given-names></name><name><surname>Rodrigues</surname><given-names>LC</given-names></name><name><surname>Sridhar</surname><given-names>S</given-names></name><name><surname>Habermann</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Effect of BCG vaccination against <italic>Mycobacterium tuberculosis</italic> infection in children: systematic review and meta-analysis</article-title>. <source>BMJ</source> (<year>2014</year>) <volume>349</volume>:<fpage>g4643</fpage>.<pub-id pub-id-type="doi">10.1136/bmj.g4643</pub-id><?supplied-pmid 25097193?><pub-id pub-id-type="pmid">25097193</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>TK</given-names></name><name><surname>Hesseling</surname><given-names>AC</given-names></name><name><surname>Hussey</surname><given-names>GD</given-names></name><name><surname>Cotton</surname><given-names>MF</given-names></name></person-group>
<article-title>Making BCG vaccination programmes safer in the HIV era</article-title>. <source>Lancet</source> (<year>2008</year>) <volume>372</volume>:<fpage>786</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(08)61318-5</pub-id><pub-id pub-id-type="pmid">18774406</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myllymaki</surname><given-names>H</given-names></name><name><surname>Niskanen</surname><given-names>M</given-names></name><name><surname>Oksanen</surname><given-names>KE</given-names></name><name><surname>Ramet</surname><given-names>M</given-names></name></person-group>
<article-title>Animal models in tuberculosis research &#x02013; where is the beef?</article-title>
<source>Expert Opin Drug Discov</source> (<year>2015</year>) <volume>10</volume>:<fpage>871</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1517/17460441.2015.1049529</pub-id><pub-id pub-id-type="pmid">26073097</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobin</surname><given-names>DM</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Comparative pathogenesis of <italic>Mycobacterium marinum</italic> and <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Cell Microbiol</source> (<year>2008</year>) <volume>10</volume>:<fpage>1027</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2008.01133.x</pub-id><?supplied-pmid 18298637?><pub-id pub-id-type="pmid">18298637</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Harrison</surname><given-names>PF</given-names></name><name><surname>Jenkin</surname><given-names>GA</given-names></name><name><surname>Davies</surname><given-names>JK</given-names></name><name><surname>Johnson</surname><given-names>PD</given-names></name><etal/></person-group>
<article-title>Insights from the complete genome sequence of <italic>Mycobacterium marinum</italic> on the evolution of <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Genome Res</source> (<year>2008</year>) <volume>18</volume>:<fpage>729</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1101/gr.075069.107</pub-id><?supplied-pmid 18403782?><pub-id pub-id-type="pmid">18403782</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barker</surname><given-names>LP</given-names></name><name><surname>George</surname><given-names>KM</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name><name><surname>Small</surname><given-names>PL</given-names></name></person-group>. <article-title>Differential trafficking of live and dead <italic>Mycobacterium marinum</italic> organisms in macrophages</article-title>. <source>Infect Immun</source> (<year>1997</year>) <volume>65</volume>:<fpage>1497</fpage>&#x02013;<lpage>504</lpage>.<?supplied-pmid 9119492?><pub-id pub-id-type="pmid">9119492</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benard</surname><given-names>EL</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Ellett</surname><given-names>F</given-names></name><name><surname>Lieschke</surname><given-names>GJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group>. <article-title>Infection of zebrafish embryos with intracellular bacterial pathogens</article-title>. <source>J Vis Exp</source> (<year>2012</year>) <volume>61:e3781</volume>.<pub-id pub-id-type="doi">10.3791/3781</pub-id><?supplied-pmid 22453760?><pub-id pub-id-type="pmid">22453760</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group>. <article-title>Protection and pathology in TB: learning from the zebrafish model</article-title>. <source>Semin Immunopathol</source> (<year>2016</year>) <volume>38</volume>(<issue>2</issue>):<fpage>261</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1007/s00281-015-0522-4</pub-id><?supplied-pmid 26324465?><pub-id pub-id-type="pmid">26324465</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Leeuwen</surname><given-names>LM</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group>. <article-title>Animal models of tuberculosis: zebrafish</article-title>. <source>Cold Spring Harb Perspect Med</source> (<year>2014</year>) <volume>5</volume>:<fpage>a018580</fpage>.<pub-id pub-id-type="doi">10.1101/cshperspect.a018580</pub-id><?supplied-pmid 25414379?><pub-id pub-id-type="pmid">25414379</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cronan</surname><given-names>MR</given-names></name><name><surname>Tobin</surname><given-names>DM</given-names></name></person-group>. <article-title>Fit for consumption: zebrafish as a model for tuberculosis</article-title>. <source>Dis Model Mech</source> (<year>2014</year>) <volume>7</volume>:<fpage>777</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1242/dmm.016089</pub-id><?supplied-pmid 24973748?><pub-id pub-id-type="pmid">24973748</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>C</given-names></name><name><surname>Flores</surname><given-names>MV</given-names></name><name><surname>Crosier</surname><given-names>K</given-names></name><name><surname>Crosier</surname><given-names>P</given-names></name></person-group>. <article-title>Live cell imaging of zebrafish leukocytes</article-title>. <source>Methods Mol Biol</source> (<year>2009</year>) <volume>546</volume>:<fpage>255</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-60327-977-2_16</pub-id><?supplied-pmid 19378109?><pub-id pub-id-type="pmid">19378109</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renshaw</surname><given-names>SA</given-names></name><name><surname>Loynes</surname><given-names>CA</given-names></name><name><surname>Trushell</surname><given-names>DM</given-names></name><name><surname>Elworthy</surname><given-names>S</given-names></name><name><surname>Ingham</surname><given-names>PW</given-names></name><name><surname>Whyte</surname><given-names>MK</given-names></name></person-group>. <article-title>A transgenic zebrafish model of neutrophilic inflammation</article-title>. <source>Blood</source> (<year>2006</year>) <volume>108</volume>:<fpage>3976</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2006-05-024075</pub-id><?supplied-pmid 16926288?><pub-id pub-id-type="pmid">16926288</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittamer</surname><given-names>V</given-names></name><name><surname>Bertrand</surname><given-names>JY</given-names></name><name><surname>Gutschow</surname><given-names>PW</given-names></name><name><surname>Traver</surname><given-names>D</given-names></name></person-group>. <article-title>Characterization of the mononuclear phagocyte system in zebrafish</article-title>. <source>Blood</source> (<year>2011</year>) <volume>117</volume>:<fpage>7126</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2010-11-321448</pub-id><?supplied-pmid 21406720?><pub-id pub-id-type="pmid">21406720</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohi</surname><given-names>O</given-names></name><name><surname>Parikka</surname><given-names>M</given-names></name><name><surname>R&#x000e4;met</surname><given-names>M</given-names></name></person-group>. <article-title>The zebrafish as a model for paediatric diseases</article-title>. <source>Acta Paediatr</source> (<year>2013</year>) <volume>102</volume>:<fpage>104</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1111/j.1651-2227.2012.02835.x</pub-id><?supplied-pmid 22924984?><pub-id pub-id-type="pmid">22924984</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>WY</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Reyon</surname><given-names>D</given-names></name><name><surname>Maeder</surname><given-names>ML</given-names></name><name><surname>Tsai</surname><given-names>SQ</given-names></name><name><surname>Sander</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>Efficient genome editing in zebrafish using a CRISPR-Cas system</article-title>. <source>Nat Biotechnol</source> (<year>2013</year>) <volume>31</volume>:<fpage>227</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nbt.2501</pub-id><?supplied-pmid 23360964?><pub-id pub-id-type="pmid">23360964</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname><given-names>GK</given-names></name><name><surname>Sood</surname><given-names>R</given-names></name><name><surname>Burgess</surname><given-names>SM</given-names></name></person-group>. <article-title>Understanding and editing the zebrafish genome</article-title>. <source>Adv Genet</source> (<year>2015</year>) <volume>92</volume>:<fpage>1</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1016/bs.adgen.2015.09.002</pub-id><?supplied-pmid 26639914?><pub-id pub-id-type="pmid">26639914</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traver</surname><given-names>D</given-names></name><name><surname>Herbomel</surname><given-names>P</given-names></name><name><surname>Patton</surname><given-names>EE</given-names></name><name><surname>Murphey</surname><given-names>RD</given-names></name><name><surname>Yoder</surname><given-names>JA</given-names></name><name><surname>Litman</surname><given-names>GW</given-names></name><etal/></person-group>
<article-title>The zebrafish as a model organism to study development of the immune system</article-title>. <source>Adv Immunol</source> (<year>2003</year>) <volume>81</volume>:<fpage>253</fpage>&#x02013;<lpage>330</lpage>.<pub-id pub-id-type="pmid">14711058</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traver</surname><given-names>D</given-names></name><name><surname>Paw</surname><given-names>BH</given-names></name><name><surname>Poss</surname><given-names>KD</given-names></name><name><surname>Penberthy</surname><given-names>WT</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Zon</surname><given-names>LI</given-names></name></person-group>. <article-title>Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>:<fpage>1238</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1038/ni1007</pub-id><?supplied-pmid 14608381?><pub-id pub-id-type="pmid">14608381</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kissa</surname><given-names>K</given-names></name><name><surname>Murayama</surname><given-names>E</given-names></name><name><surname>Zapata</surname><given-names>A</given-names></name><name><surname>Cortes</surname><given-names>A</given-names></name><name><surname>Perret</surname><given-names>E</given-names></name><name><surname>Machu</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Live imaging of emerging hematopoietic stem cells and early thymus colonization</article-title>. <source>Blood</source> (<year>2008</year>) <volume>111</volume>:<fpage>1147</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2007-07-099499</pub-id><?supplied-pmid 17934068?><pub-id pub-id-type="pmid">17934068</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lugo-Villarino</surname><given-names>G</given-names></name><name><surname>Balla</surname><given-names>KM</given-names></name><name><surname>Stachura</surname><given-names>DL</given-names></name><name><surname>Banuelos</surname><given-names>K</given-names></name><name><surname>Werneck</surname><given-names>MB</given-names></name><name><surname>Traver</surname><given-names>D</given-names></name></person-group>. <article-title>Identification of dendritic antigen-presenting cells in the zebrafish</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<fpage>15850</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1000494107</pub-id><?supplied-pmid 20733076?><pub-id pub-id-type="pmid">20733076</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koul</surname><given-names>A</given-names></name><name><surname>Herget</surname><given-names>T</given-names></name><name><surname>Klebl</surname><given-names>B</given-names></name><name><surname>Ullrich</surname><given-names>A</given-names></name></person-group>
<article-title>Interplay between mycobacteria and host signalling pathways</article-title>. <source>Nat Rev Microbiol</source> (<year>2004</year>) <volume>2</volume>:<fpage>189</fpage>&#x02013;<lpage>202</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro840</pub-id><pub-id pub-id-type="pmid">15083155</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benard</surname><given-names>EL</given-names></name><name><surname>Roobol</surname><given-names>SJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group>. <article-title>Phagocytosis of mycobacteria by zebrafish macrophages is dependent on the scavenger receptor Marco, a key control factor of pro-inflammatory signalling</article-title>. <source>Dev Comp Immunol</source> (<year>2014</year>) <volume>47</volume>:<fpage>223</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.dci.2014.07.022</pub-id><?supplied-pmid 25086293?><pub-id pub-id-type="pmid">25086293</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>IR</given-names></name><name><surname>Benard</surname><given-names>EL</given-names></name><name><surname>Hermsen</surname><given-names>T</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name><name><surname>Forlenza</surname><given-names>M</given-names></name><name><surname>Wiegertjes</surname><given-names>GF</given-names></name></person-group>. <article-title>Molecular and functional characterization of the scavenger receptor CD36 in zebrafish and common carp</article-title>. <source>Mol Immunol</source> (<year>2015</year>) <volume>63</volume>:<fpage>381</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.molimm.2014.09.010</pub-id><?supplied-pmid 25306962?><pub-id pub-id-type="pmid">25306962</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velez</surname><given-names>DR</given-names></name><name><surname>Wejse</surname><given-names>C</given-names></name><name><surname>Stryjewski</surname><given-names>ME</given-names></name><name><surname>Abbate</surname><given-names>E</given-names></name><name><surname>Hulme</surname><given-names>WF</given-names></name><name><surname>Myers</surname><given-names>JL</given-names></name><etal/></person-group>
<article-title>Variants in Toll-like receptors 2 and 9 influence susceptibility to pulmonary tuberculosis in Caucasians, African-Americans, and West Africans</article-title>. <source>Hum Genet</source> (<year>2010</year>) <volume>127</volume>:<fpage>65</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1007/s00439-009-0741-7</pub-id><pub-id pub-id-type="pmid">19771452</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name><surname>Oosting</surname><given-names>M</given-names></name><name><surname>Joosten</surname><given-names>LA</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Van Crevel</surname><given-names>R</given-names></name></person-group>. <article-title>Innate immune recognition of <italic>Mycobacterium tuberculosis</italic></article-title>. <source>Clin Dev Immunol</source> (<year>2011</year>) <volume>2011</volume>:<fpage>405310</fpage>.<pub-id pub-id-type="doi">10.1155/2011/405310</pub-id><?supplied-pmid 21603213?><pub-id pub-id-type="pmid">21603213</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benard</surname><given-names>EL</given-names></name><name><surname>Racz</surname><given-names>PI</given-names></name><name><surname>Rougeot</surname><given-names>J</given-names></name><name><surname>Nezhinsky</surname><given-names>AE</given-names></name><name><surname>Verbeek</surname><given-names>FJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><etal/></person-group>
<article-title>Macrophage-expressed perforins mpeg1 and mpeg1.2 have an anti-bacterial function in zebrafish</article-title>. <source>J Innate Immun</source> (<year>2015</year>) <volume>7</volume>:<fpage>136</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1159/000366103</pub-id><?supplied-pmid 25247677?><pub-id pub-id-type="pmid">25247677</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>van Soest</surname><given-names>JJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group>. <article-title>Functional analysis of a zebrafish myd88 mutant identifies key transcriptional components of the innate immune system</article-title>. <source>Dis Model Mech</source> (<year>2013</year>) <volume>6</volume>:<fpage>841</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1242/dmm.010843</pub-id><?supplied-pmid 23471913?><pub-id pub-id-type="pmid">23471913</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Stockhammer</surname><given-names>OW</given-names></name><name><surname>van der Laan</surname><given-names>C</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name></person-group>. <article-title>MyD88 innate immune function in a zebrafish embryo infection model</article-title>. <source>Infect Immun</source> (<year>2006</year>) <volume>74</volume>:<fpage>2436</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.74.4.2436-2441.2006</pub-id><?supplied-pmid 16552074?><pub-id pub-id-type="pmid">16552074</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elks</surname><given-names>PM</given-names></name><name><surname>Brizee</surname><given-names>S</given-names></name><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>Walmsley</surname><given-names>SR</given-names></name><name><surname>van Eeden</surname><given-names>FJ</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>Hypoxia inducible factor signaling modulates susceptibility to mycobacterial infection via a nitric oxide dependent mechanism</article-title>. <source>PLoS Pathog</source> (<year>2013</year>) <volume>9</volume>:<fpage>e1003789</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1003789</pub-id><?supplied-pmid 24367256?><pub-id pub-id-type="pmid">24367256</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elks</surname><given-names>PM</given-names></name><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>van Hensbergen</surname><given-names>V</given-names></name><name><surname>Schutz</surname><given-names>E</given-names></name><name><surname>Redd</surname><given-names>MJ</given-names></name><name><surname>Murayama</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Mycobacteria counteract a TLR-mediated nitrosative defense mechanism in a zebrafish infection model</article-title>. <source>PLoS One</source> (<year>2014</year>) <volume>9</volume>:<fpage>e100928</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0100928</pub-id><?supplied-pmid 24967596?><pub-id pub-id-type="pmid">24967596</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deretic</surname><given-names>V</given-names></name><name><surname>Saitoh</surname><given-names>T</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name></person-group>
<article-title>Autophagy in infection, inflammation and immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2013</year>) <volume>13</volume>:<fpage>722</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1038/nri3532</pub-id><pub-id pub-id-type="pmid">24064518</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Vaart</surname><given-names>M</given-names></name><name><surname>Korbee</surname><given-names>CJ</given-names></name><name><surname>Lamers</surname><given-names>GE</given-names></name><name><surname>Tengeler</surname><given-names>AC</given-names></name><name><surname>Hosseini</surname><given-names>R</given-names></name><name><surname>Haks</surname><given-names>MC</given-names></name><etal/></person-group>
<article-title>The DNA damage-regulated autophagy modulator DRAM1 links mycobacterial recognition via TLR-MYD88 to authophagic defense</article-title>. <source>Cell Host Microbe</source> (<year>2014</year>) <volume>15</volume>:<fpage>753</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2014.05.005</pub-id><pub-id pub-id-type="pmid">24922577</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>R</given-names></name><name><surname>Lamers</surname><given-names>GE</given-names></name><name><surname>Hodzic</surname><given-names>Z</given-names></name><name><surname>Meijer</surname><given-names>AH</given-names></name><name><surname>Schaaf</surname><given-names>MJ</given-names></name><name><surname>Spaink</surname><given-names>HP</given-names></name></person-group>. <article-title>Correlative light and electron microscopy imaging of autophagy in a zebrafish infection model</article-title>. <source>Autophagy</source> (<year>2014</year>) <volume>10</volume>:<fpage>1844</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.4161/auto.29992</pub-id><?supplied-pmid 25126731?><pub-id pub-id-type="pmid">25126731</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>CT</given-names></name><name><surname>Cambier</surname><given-names>CJ</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Hall</surname><given-names>CJ</given-names></name><name><surname>Crosier</surname><given-names>PS</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Neutrophils exert protection in the early tuberculous granuloma by oxidative killing of mycobacteria phagocytosed from infected macrophages</article-title>. <source>Cell Host Microbe</source> (<year>2012</year>) <volume>12</volume>:<fpage>301</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2012.07.009</pub-id><?supplied-pmid 22980327?><pub-id pub-id-type="pmid">22980327</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Looking within the zebrafish to understand the tuberculous granuloma</article-title>. <source>Adv Exp Med Biol</source> (<year>2013</year>) <volume>783</volume>:<fpage>251</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-4614-6111-1_13</pub-id><?supplied-pmid 23468113?><pub-id pub-id-type="pmid">23468113</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oehlers</surname><given-names>SH</given-names></name><name><surname>Cronan</surname><given-names>MR</given-names></name><name><surname>Scott</surname><given-names>NR</given-names></name><name><surname>Thomas</surname><given-names>MI</given-names></name><name><surname>Okuda</surname><given-names>KS</given-names></name><name><surname>Walton</surname><given-names>EM</given-names></name><etal/></person-group>
<article-title>Interception of host angiogenic signalling limits mycobacterial growth</article-title>. <source>Nature</source> (<year>2015</year>) <volume>517</volume>:<fpage>612</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature13967</pub-id><?supplied-pmid 25470057?><pub-id pub-id-type="pmid">25470057</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houben</surname><given-names>D</given-names></name><name><surname>Demangel</surname><given-names>C</given-names></name><name><surname>van Ingen</surname><given-names>J</given-names></name><name><surname>Perez</surname><given-names>J</given-names></name><name><surname>Baldeon</surname><given-names>L</given-names></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>ESX-1-mediated translocation to the cytosol controls virulence of mycobacteria</article-title>. <source>Cell Microbiol</source> (<year>2012</year>) <volume>14</volume>:<fpage>1287</fpage>&#x02013;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2012.01799.x</pub-id><?supplied-pmid 22524898?><pub-id pub-id-type="pmid">22524898</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cambier</surname><given-names>CJ</given-names></name><name><surname>Takaki</surname><given-names>KK</given-names></name><name><surname>Larson</surname><given-names>RP</given-names></name><name><surname>Hernandez</surname><given-names>RE</given-names></name><name><surname>Tobin</surname><given-names>DM</given-names></name><name><surname>Urdahl</surname><given-names>KB</given-names></name><etal/></person-group>
<article-title>Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids</article-title>. <source>Nature</source> (<year>2014</year>) <volume>505</volume>:<fpage>218</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1038/nature12799</pub-id><?supplied-pmid 24336213?><pub-id pub-id-type="pmid">24336213</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>CK</given-names></name><name><surname>White</surname><given-names>RM</given-names></name><name><surname>Zon</surname><given-names>L</given-names></name></person-group>
<article-title>Chemical genetic screening in the zebrafish embryo</article-title>. <source>Nat Protoc</source> (<year>2009</year>) <volume>4</volume>:<fpage>1422</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1038/nprot.2009.144</pub-id><pub-id pub-id-type="pmid">19745824</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>K</given-names></name><name><surname>Davis</surname><given-names>JM</given-names></name><name><surname>Winglee</surname><given-names>K</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Evaluation of the pathogenesis and treatment of <italic>Mycobacterium marinum</italic> infection in zebrafish</article-title>. <source>Nat Protoc</source> (<year>2013</year>) <volume>8</volume>:<fpage>1114</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1038/nprot.2013.068</pub-id><?supplied-pmid 23680983?><pub-id pub-id-type="pmid">23680983</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>KN</given-names></name><name><surname>Takaki</surname><given-names>K</given-names></name><name><surname>Connolly</surname><given-names>LE</given-names></name><name><surname>Wiedenhoft</surname><given-names>H</given-names></name><name><surname>Winglee</surname><given-names>K</given-names></name><name><surname>Humbert</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism</article-title>. <source>Cell</source> (<year>2011</year>) <volume>145</volume>:<fpage>39</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2011.02.022</pub-id><?supplied-pmid 21376383?><pub-id pub-id-type="pmid">21376383</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>KN</given-names></name><name><surname>Szumowski</surname><given-names>JD</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>
<article-title>Verapamil, and its metabolite norverapamil, inhibit macrophage-induced, bacterial efflux pump-mediated tolerance to multiple anti-tubercular drugs</article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>210</volume>:<fpage>456</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiu095</pub-id><pub-id pub-id-type="pmid">24532601</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torraca</surname><given-names>V</given-names></name><name><surname>Cui</surname><given-names>C</given-names></name><name><surname>Boland</surname><given-names>R</given-names></name><name><surname>Bebelman</surname><given-names>JP</given-names></name><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Smit</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>The CXCR3-CXCL11 signaling axis mediates macrophage recruitment and dissemination of mycobacterial infection</article-title>. <source>Dis Model Mech</source> (<year>2015</year>) <volume>8</volume>:<fpage>253</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1242/dmm.017756</pub-id><?supplied-pmid 25573892?><pub-id pub-id-type="pmid">25573892</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobin</surname><given-names>DM</given-names></name><name><surname>Roca</surname><given-names>FJ</given-names></name><name><surname>Oh</surname><given-names>SF</given-names></name><name><surname>McFarland</surname><given-names>R</given-names></name><name><surname>Vickery</surname><given-names>TW</given-names></name><name><surname>Ray</surname><given-names>JP</given-names></name><etal/></person-group>
<article-title>Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections</article-title>. <source>Cell</source> (<year>2012</year>) <volume>148</volume>:<fpage>434</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2011.12.023</pub-id><?supplied-pmid 22304914?><pub-id pub-id-type="pmid">22304914</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roca</surname><given-names>FJ</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species</article-title>. <source>Cell</source> (<year>2013</year>) <volume>153</volume>:<fpage>521</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2013.03.022</pub-id><?supplied-pmid 23582643?><pub-id pub-id-type="pmid">23582643</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Lange</surname><given-names>C</given-names></name><name><surname>Rao</surname><given-names>M</given-names></name><name><surname>Balaji</surname><given-names>KN</given-names></name><name><surname>Lotze</surname><given-names>M</given-names></name><name><surname>Schito</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Progress in tuberculosis vaccine development and host-directed therapies &#x02013; a state of the art review</article-title>. <source>Lancet Respir Med</source> (<year>2014</year>) <volume>2</volume>:<fpage>301</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1016/S2213-2600(14)70033-5</pub-id><pub-id pub-id-type="pmid">24717627</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Hou</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name></person-group>. <article-title>New insights into the pathogenesis of tuberculosis revealed by <italic>Mycobacterium marinum</italic>: the zebrafish model from the systems biology perspective</article-title>. <source>Crit Rev Eukaryot Gene Expr</source> (<year>2011</year>) <volume>21</volume>:<fpage>337</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1615/CritRevEukarGeneExpr.v21.i4.40</pub-id><?supplied-pmid 22181703?><pub-id pub-id-type="pmid">22181703</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Case</surname><given-names>ED</given-names></name><name><surname>Samuel</surname><given-names>JE</given-names></name></person-group>. <article-title>Contrasting lifestyles within the host cell</article-title>. <source>Microbiol Spectr</source> (<year>2016</year>) <volume>4</volume>.<pub-id pub-id-type="doi">10.1128/microbiolspec.VMBF-0014-2015</pub-id><?supplied-pmid 26999394?><pub-id pub-id-type="pmid">26999394</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oksanen</surname><given-names>KE</given-names></name><name><surname>Halfpenny</surname><given-names>NJ</given-names></name><name><surname>Sherwood</surname><given-names>E</given-names></name><name><surname>Harjula</surname><given-names>SK</given-names></name><name><surname>Hammaren</surname><given-names>MM</given-names></name><name><surname>Ahava</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>An adult zebrafish model for preclinical tuberculosis vaccine development</article-title>. <source>Vaccine</source> (<year>2013</year>) <volume>31</volume>:<fpage>5202</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2013.08.093</pub-id><?supplied-pmid 24055305?><pub-id pub-id-type="pmid">24055305</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojanen</surname><given-names>MJ</given-names></name><name><surname>Turpeinen</surname><given-names>H</given-names></name><name><surname>Cordova</surname><given-names>ZM</given-names></name><name><surname>Hammaren</surname><given-names>MM</given-names></name><name><surname>Harjula</surname><given-names>SK</given-names></name><name><surname>Parikka</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>The proprotein convertase subtilisin/kexin furinA regulates zebrafish host response against <italic>Mycobacterium marinum</italic></article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>:<fpage>1431</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.03135-14</pub-id><?supplied-pmid 25624351?><pub-id pub-id-type="pmid">25624351</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammaren</surname><given-names>MM</given-names></name><name><surname>Oksanen</surname><given-names>KE</given-names></name><name><surname>Nisula</surname><given-names>HM</given-names></name><name><surname>Luukinen</surname><given-names>BV</given-names></name><name><surname>Pesu</surname><given-names>M</given-names></name><name><surname>Ramet</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Adequate Th2-type response associates with restricted bacterial growth in latent mycobacterial infection of zebrafish</article-title>. <source>PLoS Pathog</source> (<year>2014</year>) <volume>10</volume>:<fpage>e1004190</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1004190</pub-id><?supplied-pmid 24968056?><pub-id pub-id-type="pmid">24968056</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Haks</surname><given-names>MC</given-names></name><name><surname>Caccamo</surname><given-names>N</given-names></name><name><surname>Dieli</surname><given-names>F</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name></person-group>. <article-title>Human CD8+ T-cells recognizing peptides from <italic>Mycobacterium tuberculosis</italic> (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset</article-title>. <source>PLoS Pathog</source> (<year>2015</year>) <volume>11</volume>:<fpage>e1004671</fpage>.<pub-id pub-id-type="doi">10.1371/journal.ppat.1004671</pub-id><?supplied-pmid 25803478?><pub-id pub-id-type="pmid">25803478</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Sar</surname><given-names>AM</given-names></name><name><surname>Abdallah</surname><given-names>AM</given-names></name><name><surname>Sparrius</surname><given-names>M</given-names></name><name><surname>Reinders</surname><given-names>E</given-names></name><name><surname>Vandenbroucke-Grauls</surname><given-names>CM</given-names></name><name><surname>Bitter</surname><given-names>W</given-names></name></person-group>. <article-title><italic>Mycobacterium marinum</italic> strains can be divided into two distinct types based on genetic diversity and virulence</article-title>. <source>Infect Immun</source> (<year>2004</year>) <volume>72</volume>:<fpage>6306</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.72.11.6306-6312.2004</pub-id><?supplied-pmid 15501758?><pub-id pub-id-type="pmid">15501758</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oksanen</surname><given-names>KE</given-names></name><name><surname>Myllym&#x000e4;ki</surname><given-names>H</given-names></name><name><surname>Ahava</surname><given-names>MJ</given-names></name><name><surname>M&#x000e4;kinen</surname><given-names>L</given-names></name><name><surname>Parikka</surname><given-names>M</given-names></name><name><surname>R&#x000e4;met</surname><given-names>M</given-names></name></person-group>. <article-title>DNA vaccination boosts Bacillus Calmette-Gu&#x000e9;rin protection against mycobacterial infection in zebrafish</article-title>. <source>Dev Comp Immunol</source> (<year>2016</year>) <volume>54</volume>:<fpage>89</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="doi">10.1016/j.dci.2015.09.001</pub-id><?supplied-pmid 26363085?><pub-id pub-id-type="pmid">26363085</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>Z</given-names></name><name><surname>Samuel-Shaker</surname><given-names>D</given-names></name><name><surname>Watral</surname><given-names>V</given-names></name><name><surname>Kent</surname><given-names>ML</given-names></name></person-group>
<article-title>Attenuated <italic>Mycobacterium marinum</italic> protects zebrafish against mycobacteriosis</article-title>. <source>J Fish Dis</source> (<year>2010</year>) <volume>33</volume>:<fpage>371</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2761.2009.01115.x</pub-id><pub-id pub-id-type="pmid">19912456</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoop</surname><given-names>EJ</given-names></name><name><surname>Schipper</surname><given-names>T</given-names></name><name><surname>Rosendahl Huber</surname><given-names>SK</given-names></name><name><surname>Nezhinsky</surname><given-names>AE</given-names></name><name><surname>Verbeek</surname><given-names>FJ</given-names></name><name><surname>Gurcha</surname><given-names>SS</given-names></name><etal/></person-group>
<article-title>Zebrafish embryo screen for mycobacterial genes involved in the initiation of granuloma formation reveals a newly identified ESX-1 component</article-title>. <source>Dis Model Mech</source> (<year>2011</year>) <volume>4</volume>:<fpage>526</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1242/dmm.006676</pub-id><?supplied-pmid 21372049?><pub-id pub-id-type="pmid">21372049</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volkman</surname><given-names>HE</given-names></name><name><surname>Clay</surname><given-names>H</given-names></name><name><surname>Beery</surname><given-names>D</given-names></name><name><surname>Chang</surname><given-names>JC</given-names></name><name><surname>Sherman</surname><given-names>DR</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group>. <article-title>Tuberculous granuloma formation is enhanced by a mycobacterium virulence determinant</article-title>. <source>PLoS Biol</source> (<year>2004</year>) <volume>2</volume>:<fpage>e367</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pbio.0020367</pub-id><?supplied-pmid 15510227?><pub-id pub-id-type="pmid">15510227</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knudsen</surname><given-names>NP</given-names></name><name><surname>Norskov-Lauritsen</surname><given-names>S</given-names></name><name><surname>Dolganov</surname><given-names>GM</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name><name><surname>Lindenstrom</surname><given-names>T</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Tuberculosis vaccine with high predicted population coverage and compatibility with modern diagnostics</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2014</year>) <volume>111</volume>:<fpage>1096</fpage>&#x02013;<lpage>101</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1314973111</pub-id><?supplied-pmid 24395772?><pub-id pub-id-type="pmid">24395772</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoang</surname><given-names>T</given-names></name><name><surname>Aagaard</surname><given-names>C</given-names></name><name><surname>Dietrich</surname><given-names>J</given-names></name><name><surname>Cassidy</surname><given-names>JP</given-names></name><name><surname>Dolganov</surname><given-names>G</given-names></name><name><surname>Schoolnik</surname><given-names>GK</given-names></name><etal/></person-group>
<article-title>ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e80579</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0080579</pub-id><?supplied-pmid 24349004?><pub-id pub-id-type="pmid">24349004</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottai</surname><given-names>D</given-names></name><name><surname>Frigui</surname><given-names>W</given-names></name><name><surname>Clark</surname><given-names>S</given-names></name><name><surname>Rayner</surname><given-names>E</given-names></name><name><surname>Zelmer</surname><given-names>A</given-names></name><name><surname>Andreu</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system</article-title>. <source>Vaccine</source> (<year>2015</year>) <volume>33</volume>:<fpage>2710</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.03.083</pub-id><?supplied-pmid 25869896?><pub-id pub-id-type="pmid">25869896</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>PL</given-names></name><name><surname>Dietrich</surname><given-names>J</given-names></name><name><surname>Tan</surname><given-names>E</given-names></name><name><surname>Abalos</surname><given-names>RM</given-names></name><name><surname>Burgos</surname><given-names>J</given-names></name><name><surname>Bigbee</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Clin Invest</source> (<year>2012</year>) <volume>122</volume>:<fpage>303</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1172/JCI46252</pub-id><?supplied-pmid 22133873?><pub-id pub-id-type="pmid">22133873</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>J</given-names></name><name><surname>Andersen</surname><given-names>C</given-names></name><name><surname>Rappuoli</surname><given-names>R</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name><name><surname>Jensen</surname><given-names>CG</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name></person-group>. <article-title>Mucosal administration of Ag85B-ESAT-6 protects against infection with <italic>Mycobacterium tuberculosis</italic> and boosts prior bacillus Calmette-Guerin immunity</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<fpage>6353</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.9.6353</pub-id><?supplied-pmid 17056566?><pub-id pub-id-type="pmid">17056566</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Xiang</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice</article-title>. <source>Vaccine</source> (<year>2012</year>) <volume>30</volume>:<fpage>2490</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2011.06.029</pub-id><?supplied-pmid 21704108?><pub-id pub-id-type="pmid">21704108</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capuano</surname><given-names>SVI</given-names></name><name><surname>Croix</surname><given-names>DA</given-names></name><name><surname>Pawar</surname><given-names>S</given-names></name><name><surname>Zinovik</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>PL</given-names></name><etal/></person-group>
<article-title>Experimental <italic>Mycobacterium tuberculosis</italic> infection of cynomolgus macaques closely resembles the various manifestations of human <italic>M. tuberculosis</italic> infection</article-title>. <source>Infect Immun</source> (<year>2003</year>) <volume>71</volume>:<fpage>5831</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.71.10.5831-5844.2003</pub-id><?supplied-pmid 14500505?><pub-id pub-id-type="pmid">14500505</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>KN</given-names></name><name><surname>Bauer</surname><given-names>J</given-names></name><name><surname>Tallen</surname><given-names>A</given-names></name><name><surname>Matthews</surname><given-names>JL</given-names></name><name><surname>Westerfield</surname><given-names>M</given-names></name><name><surname>Varga</surname><given-names>ZM</given-names></name></person-group>. <article-title>Characterization and management of asymptomatic mycobacterium infections at the Zebrafish International Resource Center</article-title>. <source>J Am Assoc Lab Anim Sci</source> (<year>2011</year>) <volume>50</volume>:<fpage>675</fpage>&#x02013;<lpage>9</lpage>.<?supplied-pmid 22330714?><pub-id pub-id-type="pmid">22330714</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pasnik</surname><given-names>DJ</given-names></name><name><surname>Smith</surname><given-names>SA</given-names></name></person-group>. <article-title>Immunogenic and protective effects of a DNA vaccine for <italic>Mycobacterium marinum</italic> in fish</article-title>. <source>Vet Immunol Immunopathol</source> (<year>2005</year>) <volume>103</volume>:<fpage>195</fpage>&#x02013;<lpage>206</lpage>.<pub-id pub-id-type="doi">10.1016/j.vetimm.2004.08.017</pub-id><?supplied-pmid 15621306?><pub-id pub-id-type="pmid">15621306</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>G</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name><name><surname>Aoki</surname><given-names>T</given-names></name><name><surname>Hirono</surname><given-names>I</given-names></name></person-group>. <article-title>BCG vaccine confers adaptive immunity against <italic>Mycobacterium</italic> sp. infection in fish</article-title>. <source>Dev Comp Immunol</source> (<year>2010</year>) <volume>34</volume>:<fpage>133</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.dci.2009.08.013</pub-id><?supplied-pmid 19733586?><pub-id pub-id-type="pmid">19733586</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>. <article-title>The immunological life cycle of tuberculosis</article-title>. <source>Nat Rev Immunol</source> (<year>2012</year>) <volume>12</volume>:<fpage>581</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1038/nri3259</pub-id><?supplied-pmid 22790178?><pub-id pub-id-type="pmid">22790178</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>:<fpage>973</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Dorhoi</surname><given-names>A</given-names></name></person-group>. <article-title>Inflammation in tuberculosis: interactions, imbalances and interventions</article-title>. <source>Curr Opin Immunol</source> (<year>2013</year>) <volume>25</volume>:<fpage>441</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.coi.2013.05.005</pub-id><?supplied-pmid 23725875?><pub-id pub-id-type="pmid">23725875</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>HA</given-names></name></person-group>. <article-title>Profiling the host immune response to tuberculosis vaccines</article-title>. <source>Vaccine</source> (<year>2015</year>) <volume>33</volume>:<fpage>5313</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/j.vaccine.2015.07.090</pub-id><?supplied-pmid 26241949?><pub-id pub-id-type="pmid">26241949</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tameris</surname><given-names>MD</given-names></name><name><surname>Hatherill</surname><given-names>M</given-names></name><name><surname>Landry</surname><given-names>BS</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Snowden</surname><given-names>MA</given-names></name><name><surname>Lockhart</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial</article-title>. <source>Lancet</source> (<year>2013</year>) <volume>381</volume>:<fpage>1021</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(13)60177-4</pub-id><?supplied-pmid 23391465?><pub-id pub-id-type="pmid">23391465</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagina</surname><given-names>BM</given-names></name><name><surname>Abel</surname><given-names>B</given-names></name><name><surname>Scriba</surname><given-names>TJ</given-names></name><name><surname>Hughes</surname><given-names>EJ</given-names></name><name><surname>Keyser</surname><given-names>A</given-names></name><name><surname>Soares</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after Bacillus Calmette-Gu&#x000e9;rin vaccination of newborns</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2010</year>) <volume>182</volume>:<fpage>1073</fpage><pub-id pub-id-type="doi">10.1164/rccm.201003-0334OC</pub-id><pub-id pub-id-type="pmid">20558627</pub-id></mixed-citation></ref></ref-list></back></article>